GLOW

Description

Scientific overview

GLOW is a fixed-composition, three-peptide blend supplied for laboratory research. Each vial contains GHK-Cu 50 mg, BPC-157 10 mg, and TB-500 10 mg, providing a total nominal peptide content of 70 mg.

GHK-Cu is a copper-binding tripeptide complex investigated in fibroblast cultures and animal models for signaling associated with extracellular-matrix synthesis and remodeling. BPC-157 is a synthetic pentadecapeptide studied predominantly in preclinical models; controlled human pharmacokinetic, safety, and efficacy evidence remains limited. TB-500 is an acetylated thymosin-beta-4-derived peptide fragment studied in analytical, cell, and animal research.

The three components have distinct molecular identities and should be evaluated accordingly. Findings for an individual component do not establish the behavior, safety, or efficacy of the fixed combination.

Research characteristics

• Molecular class: multi-peptide research blend
• GHK-Cu content: 50 mg
• BPC-157 content: 10 mg
• TB-500 content: 10 mg
• Total peptide content: 70 mg
• Research focus: peptide signaling, extracellular-matrix biology, and controlled in-vitro or analytical investigation
• Evidence context: research on these components is largely preclinical; this blend is not an approved clinical product

Research-use notice: Supplied for laboratory research only. Not for human or veterinary use, diagnosis, treatment, or consumption. No medical or therapeutic claims are made.

Blend composition